Intercept Pharmaceuticals reported $-7528000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -34.01M 79.04M
Acorda Therapeutics ACOR:US $ -46.68M 22.16M
Alnylam Pharmaceuticals ALNY:US $ -277.4M 37.06M
Amarin AMRN:US $ -69.96M 38.39M
Amgen AMGN:US $ 1317M 159M
Arrowhead Research ARWR:US $ -72046000 116.41M
AstraZeneca AZN:LN 29568.96M 177.38M
Biogen BIIB:US $ 1058M 754.2M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Bristol Myers Squibb BMY:US $ 1421M 143M
Eli Lilly And LLY:US $ 952.5M 950.4M
Enanta Pharmaceuticals ENTA:US $ -31.7M 1.89M
Esperion Therapeutics ESPR:US $ -66324000 9.59M
Galectin Therapeutics GALT:US $ -9.61M 0.32M
Gilead Sciences GILD:US $ 1144M 1125M
GlaxoSmithKline GSK:LN 83800M 96400M
Intercept Pharmaceuticals ICPT:US $ -7.53M 9.76M
IONIS PHARMACEUT IONS:US $ -105.14M 39.97M
Moderna Inc MRNA:US 2.2B 1.46B
Neurocrine Biosciences NBIX:US $ -16.9M 30.8M
Novartis NOVN:VX SF 1694M 528M
Ptc Therapeutics PTCT:US $ -152.09M 25.36M
Regeneron Pharmaceuticals REGN:US $ 852.1M 121.4M
Sangamo Biosciences SGMO:US $ -43.17M 0.8M
Sarepta Therapeutics SRPT:US $ -231.48M 126.46M
Vertex Pharmaceuticals VRTX:US $ 810.5M 48.4M
YTE INCY:US $ 161.43M 123.44M